Growth Strategy

AMIC is well-positioned for manufacturing, marketing, and distributing a wide range of radiopharmaceuticals and radiochemicals to the nuclear medicine industry, an endeavor representing the merger of medicine and biology.  AMIC is forging commercial partnerships and university affiliations to further its manufacturing capabilities and distribution network.

Key Relationships

• Completed a strategic acquisition of a competitive firm, thereby establishing AMIC’s position as a marketplace supplier through international sales of the O-18 isotope.
• AMIC has formalized working relationships with three universities (SUNY Buffalo, Idaho State University, and University of Missouri) as well as with three U.S. national laboratories (Pacific Northwest National Laboratory, Los Alamos National Laboratory, and Lawrence Berkeley National Laboratory) engaged in isotope production and application research.
• AMIC commenced three international advanced technology collaborative development projects for production and isotopic separation capability, offering high-value products not available from other sources.
• Initiated discussions for the construction of regional PET isotope production centers in Los Angeles, California and Oahu, Hawaii.
• AMIC began formal negotiations for the creation of strategic relationships to produce and sell medical isotopes in Taiwan and China.
• Completed construction of AMIC’s Washington State isotope production center and processing laboratory, and signed its first supply contract with a regional medical center.

Current Products

• AMIC has evaluated a range of potential medical isotope products for a variety of applications including, but not limited to, PET imaging, which is used for cancer diagnosis, staging and research, heart and brain imaging and evaluation of neurological diseases as Alzheimer’s, epilepsy and Parkinson’s, as well as stem cell research and a potentially promising treatment for HIV/AIDS. Many of the isotopes used for the above indications are not limited to a single production method, but can be manufactured in a varietyof accelerator types and configurations.
• Of the isotopes on AMIC’s list of potentials, AMIC currently imports and offers worldwide distribution of O-18, a rare and stable isotope target for making the PET isotope F-18.
• AMIC currently manufactures F-18 and FDG, a glucose analog, used in PET imaging.
• Development of the additional product lines will be added to the company as the cost of goods and marketplace information matures.